img

Global Intravenous (IV) Iron Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Intravenous (IV) Iron Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Intravenous (IV) Iron Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Intravenous (IV) Iron Drugs market is projected to reach US$ 1899.3 million in 2034, increasing from US$ 1430.8 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2034. Demand from Nephrology and Gynecology & Obstetrics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Intravenous (IV) Iron Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Intravenous (IV) Iron Drugs key manufacturers include Sanofi US, Allergan, AMAG Pharmaceuticals, Dalichi Sankyo, Luitpold Pharmaceuticals, Pharmacosmos and Takeda Pharmaceutical, etc. Sanofi US, Allergan, AMAG Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Intravenous (IV) Iron Drugs can be divided into Ferric Carboxymaltose, Iron Sucrose, Iron Dextran and Others, etc. Ferric Carboxymaltose is the mainstream product in the market, accounting for % sales share globally in 2022.
Intravenous (IV) Iron Drugs is widely used in various fields, such as Nephrology, Gynecology & Obstetrics, Gastroenterology and Oncology, etc. Nephrology provides greatest supports to the Intravenous (IV) Iron Drugs industry development. In 2022, global % sales of Intravenous (IV) Iron Drugs went into Nephrology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intravenous (IV) Iron Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi US
Allergan
AMAG Pharmaceuticals
Dalichi Sankyo
Luitpold Pharmaceuticals
Pharmacosmos
Takeda Pharmaceutical
Segment by Type
Ferric Carboxymaltose
Iron Sucrose
Iron Dextran
Others

Segment by Application


Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Intravenous (IV) Iron Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Intravenous (IV) Iron Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Intravenous (IV) Iron Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Intravenous (IV) Iron Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Intravenous (IV) Iron Drugs introduction, etc. Intravenous (IV) Iron Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Intravenous (IV) Iron Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Intravenous (IV) Iron Drugs Market Overview
1.1 Intravenous (IV) Iron Drugs Product Overview
1.2 Intravenous (IV) Iron Drugs Market Segment by Type
1.2.1 Ferric Carboxymaltose
1.2.2 Iron Sucrose
1.2.3 Iron Dextran
1.2.4 Others
1.3 Global Intravenous (IV) Iron Drugs Market Size by Type
1.3.1 Global Intravenous (IV) Iron Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Intravenous (IV) Iron Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Intravenous (IV) Iron Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intravenous (IV) Iron Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Intravenous (IV) Iron Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Intravenous (IV) Iron Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Intravenous (IV) Iron Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Intravenous (IV) Iron Drugs Sales Breakdown by Type (2018-2024)
2 Global Intravenous (IV) Iron Drugs Market Competition by Company
2.1 Global Top Players by Intravenous (IV) Iron Drugs Sales (2018-2024)
2.2 Global Top Players by Intravenous (IV) Iron Drugs Revenue (2018-2024)
2.3 Global Top Players by Intravenous (IV) Iron Drugs Price (2018-2024)
2.4 Global Top Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intravenous (IV) Iron Drugs Market Competitive Situation and Trends
2.5.1 Intravenous (IV) Iron Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Intravenous (IV) Iron Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Intravenous (IV) Iron Drugs Market
2.8 Key Manufacturers Intravenous (IV) Iron Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intravenous (IV) Iron Drugs Status and Outlook by Region
3.1 Global Intravenous (IV) Iron Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Intravenous (IV) Iron Drugs Historic Market Size by Region
3.2.1 Global Intravenous (IV) Iron Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Intravenous (IV) Iron Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Intravenous (IV) Iron Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Intravenous (IV) Iron Drugs Forecasted Market Size by Region
3.3.1 Global Intravenous (IV) Iron Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Intravenous (IV) Iron Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Intravenous (IV) Iron Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Intravenous (IV) Iron Drugs by Application
4.1 Intravenous (IV) Iron Drugs Market Segment by Application
4.1.1 Nephrology
4.1.2 Gynecology & Obstetrics
4.1.3 Gastroenterology
4.1.4 Oncology
4.1.5 Cardiology
4.1.6 Others
4.2 Global Intravenous (IV) Iron Drugs Market Size by Application
4.2.1 Global Intravenous (IV) Iron Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Intravenous (IV) Iron Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Intravenous (IV) Iron Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intravenous (IV) Iron Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Intravenous (IV) Iron Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Intravenous (IV) Iron Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Intravenous (IV) Iron Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Intravenous (IV) Iron Drugs Sales Breakdown by Application (2018-2024)
5 North America Intravenous (IV) Iron Drugs by Country
5.1 North America Intravenous (IV) Iron Drugs Historic Market Size by Country
5.1.1 North America Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Intravenous (IV) Iron Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Intravenous (IV) Iron Drugs Sales in Value by Country (2018-2024)
5.2 North America Intravenous (IV) Iron Drugs Forecasted Market Size by Country
5.2.1 North America Intravenous (IV) Iron Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Intravenous (IV) Iron Drugs Sales in Value by Country (2024-2034)
6 Europe Intravenous (IV) Iron Drugs by Country
6.1 Europe Intravenous (IV) Iron Drugs Historic Market Size by Country
6.1.1 Europe Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Intravenous (IV) Iron Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Intravenous (IV) Iron Drugs Sales in Value by Country (2018-2024)
6.2 Europe Intravenous (IV) Iron Drugs Forecasted Market Size by Country
6.2.1 Europe Intravenous (IV) Iron Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Intravenous (IV) Iron Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Intravenous (IV) Iron Drugs by Region
7.1 Asia-Pacific Intravenous (IV) Iron Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Intravenous (IV) Iron Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Intravenous (IV) Iron Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Intravenous (IV) Iron Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Intravenous (IV) Iron Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Intravenous (IV) Iron Drugs Sales in Value by Region (2024-2034)
8 Latin America Intravenous (IV) Iron Drugs by Country
8.1 Latin America Intravenous (IV) Iron Drugs Historic Market Size by Country
8.1.1 Latin America Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Intravenous (IV) Iron Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Intravenous (IV) Iron Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Intravenous (IV) Iron Drugs Forecasted Market Size by Country
8.2.1 Latin America Intravenous (IV) Iron Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Intravenous (IV) Iron Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Intravenous (IV) Iron Drugs by Country
9.1 Middle East and Africa Intravenous (IV) Iron Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Intravenous (IV) Iron Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Intravenous (IV) Iron Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Intravenous (IV) Iron Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Intravenous (IV) Iron Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Intravenous (IV) Iron Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Intravenous (IV) Iron Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi US
10.1.1 Sanofi US Company Information
10.1.2 Sanofi US Introduction and Business Overview
10.1.3 Sanofi US Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi US Intravenous (IV) Iron Drugs Products Offered
10.1.5 Sanofi US Recent Development
10.2 Allergan
10.2.1 Allergan Company Information
10.2.2 Allergan Introduction and Business Overview
10.2.3 Allergan Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Allergan Intravenous (IV) Iron Drugs Products Offered
10.2.5 Allergan Recent Development
10.3 AMAG Pharmaceuticals
10.3.1 AMAG Pharmaceuticals Company Information
10.3.2 AMAG Pharmaceuticals Introduction and Business Overview
10.3.3 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Products Offered
10.3.5 AMAG Pharmaceuticals Recent Development
10.4 Dalichi Sankyo
10.4.1 Dalichi Sankyo Company Information
10.4.2 Dalichi Sankyo Introduction and Business Overview
10.4.3 Dalichi Sankyo Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Dalichi Sankyo Intravenous (IV) Iron Drugs Products Offered
10.4.5 Dalichi Sankyo Recent Development
10.5 Luitpold Pharmaceuticals
10.5.1 Luitpold Pharmaceuticals Company Information
10.5.2 Luitpold Pharmaceuticals Introduction and Business Overview
10.5.3 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Products Offered
10.5.5 Luitpold Pharmaceuticals Recent Development
10.6 Pharmacosmos
10.6.1 Pharmacosmos Company Information
10.6.2 Pharmacosmos Introduction and Business Overview
10.6.3 Pharmacosmos Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Pharmacosmos Intravenous (IV) Iron Drugs Products Offered
10.6.5 Pharmacosmos Recent Development
10.7 Takeda Pharmaceutical
10.7.1 Takeda Pharmaceutical Company Information
10.7.2 Takeda Pharmaceutical Introduction and Business Overview
10.7.3 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Takeda Pharmaceutical Intravenous (IV) Iron Drugs Products Offered
10.7.5 Takeda Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intravenous (IV) Iron Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intravenous (IV) Iron Drugs Industrial Chain Analysis
11.4 Intravenous (IV) Iron Drugs Market Dynamics
11.4.1 Intravenous (IV) Iron Drugs Industry Trends
11.4.2 Intravenous (IV) Iron Drugs Market Drivers
11.4.3 Intravenous (IV) Iron Drugs Market Challenges
11.4.4 Intravenous (IV) Iron Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intravenous (IV) Iron Drugs Distributors
12.3 Intravenous (IV) Iron Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Ferric Carboxymaltose
Table 2. Major Company of Iron Sucrose
Table 3. Major Company of Iron Dextran
Table 4. Major Company of Others
Table 5. Global Intravenous (IV) Iron Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (K Units)
Table 7. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (US& Million)
Table 9. Global Intravenous (IV) Iron Drugs Market Share in Value by Type (2018-2024)
Table 10. Global Intravenous (IV) Iron Drugs Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Intravenous (IV) Iron Drugs Sales by Type (2024-2034) & (K Units)
Table 12. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Intravenous (IV) Iron Drugs Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Type (2024-2034)
Table 15. Global Intravenous (IV) Iron Drugs Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (K Units)
Table 17. North America Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Intravenous (IV) Iron Drugs Sales (K Units) by Type (2018-2024)
Table 19. Europe Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Intravenous (IV) Iron Drugs Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Intravenous (IV) Iron Drugs Sales (K Units) by Type (2018-2024)
Table 23. Latin America Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Intravenous (IV) Iron Drugs Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Intravenous (IV) Iron Drugs Sales by Company (2018-2024) & (K Units)
Table 27. Global Intravenous (IV) Iron Drugs Sales Share by Company (2018-2024)
Table 28. Global Intravenous (IV) Iron Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Intravenous (IV) Iron Drugs Revenue Share by Company (2018-2024)
Table 30. Global Market Intravenous (IV) Iron Drugs Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Intravenous (IV) Iron Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Intravenous (IV) Iron Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Iron Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Intravenous (IV) Iron Drugs Market
Table 35. Key Manufacturers Intravenous (IV) Iron Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Intravenous (IV) Iron Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Intravenous (IV) Iron Drugs Sales by Region (2018-2024) & (K Units)
Table 39. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Intravenous (IV) Iron Drugs Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Region (2018-2024)
Table 42. Global Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Intravenous (IV) Iron Drugs Sales by Region (2024-2034) & (K Units)
Table 44. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Intravenous (IV) Iron Drugs Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Region (2024-2034)
Table 47. Global Intravenous (IV) Iron Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Intravenous (IV) Iron Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (K Units)
Table 50. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Application (2018-2024)
Table 53. Global Intravenous (IV) Iron Drugs Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Intravenous (IV) Iron Drugs Sales by Application (2024-2034) & (K Units)
Table 55. Global Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Intravenous (IV) Iron Drugs Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Intravenous (IV) Iron Drugs Sales Market Share in Value by Application (2024-2034)
Table 58. Global Intravenous (IV) Iron Drugs Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Intravenous (IV) Iron Drugs Sales by Application (2018-2024) (K Units)
Table 60. North America Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Intravenous (IV) Iron Drugs Sales by Application (2018-2024) (K Units)
Table 62. Europe Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Intravenous (IV) Iron Drugs Sales by Application (2018-2024) (K Units)
Table 66. Latin America Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (K Units)
Table 70. North America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Intravenous (IV) Iron Drugs Sales Market Share in Value by Country (2018-2024)
Table 73. North America Intravenous (IV) Iron Drugs Sales by Country (2024-2034) & (K Units)
Table 74. North America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Intravenous (IV) Iron Drugs Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Intravenous (IV) Iron Drugs Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (K Units)
Table 78. Europe Intravenous (IV) Iron Drugs Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Intravenous (IV) Iron Drugs Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Intravenous (IV) Iron Drugs Sales by Country (2024-2034) & (K Units)
Table 82. Europe Intravenous (IV) Iron Drugs Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Intravenous (IV) Iron Drugs Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Intravenous (IV) Iron Drugs Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Intravenous (IV) Iron Drugs Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Intravenous (IV) Iron Drugs Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Intravenous (IV) Iron Drugs Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Intravenous (IV) Iron Drugs Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Value by Country (2024-2034)
Table 109. Sanofi US Company Information
Table 110. Sanofi US Introduction and Business Overview
Table 111. Sanofi US Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Sanofi US Intravenous (IV) Iron Drugs Product
Table 113. Sanofi US Recent Development
Table 114. Allergan Company Information
Table 115. Allergan Introduction and Business Overview
Table 116. Allergan Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Allergan Intravenous (IV) Iron Drugs Product
Table 118. Allergan Recent Development
Table 119. AMAG Pharmaceuticals Company Information
Table 120. AMAG Pharmaceuticals Introduction and Business Overview
Table 121. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Product
Table 123. AMAG Pharmaceuticals Recent Development
Table 124. Dalichi Sankyo Company Information
Table 125. Dalichi Sankyo Introduction and Business Overview
Table 126. Dalichi Sankyo Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Dalichi Sankyo Intravenous (IV) Iron Drugs Product
Table 128. Dalichi Sankyo Recent Development
Table 129. Luitpold Pharmaceuticals Company Information
Table 130. Luitpold Pharmaceuticals Introduction and Business Overview
Table 131. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Product
Table 133. Luitpold Pharmaceuticals Recent Development
Table 134. Pharmacosmos Company Information
Table 135. Pharmacosmos Introduction and Business Overview
Table 136. Pharmacosmos Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Pharmacosmos Intravenous (IV) Iron Drugs Product
Table 138. Pharmacosmos Recent Development
Table 139. Takeda Pharmaceutical Company Information
Table 140. Takeda Pharmaceutical Introduction and Business Overview
Table 141. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Takeda Pharmaceutical Intravenous (IV) Iron Drugs Product
Table 143. Takeda Pharmaceutical Recent Development
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Intravenous (IV) Iron Drugs Market Trends
Table 147. Intravenous (IV) Iron Drugs Market Drivers
Table 148. Intravenous (IV) Iron Drugs Market Challenges
Table 149. Intravenous (IV) Iron Drugs Market Restraints
Table 150. Intravenous (IV) Iron Drugs Distributors List
Table 151. Intravenous (IV) Iron Drugs Downstream Customers
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous (IV) Iron Drugs Product Picture
Figure 2. Global Intravenous (IV) Iron Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Intravenous (IV) Iron Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Intravenous (IV) Iron Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Ferric Carboxymaltose
Figure 6. Global Ferric Carboxymaltose Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Iron Sucrose
Figure 8. Global Iron Sucrose Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Iron Dextran
Figure 10. Global Iron Dextran Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Intravenous (IV) Iron Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Intravenous (IV) Iron Drugs Sales Market Share by Type in 2022 & 2034
Figure 15. North America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Intravenous (IV) Iron Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Intravenous (IV) Iron Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous (IV) Iron Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous (IV) Iron Drugs Revenue in 2022
Figure 27. Intravenous (IV) Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Nephrology
Figure 29. Global Nephrology Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Gynecology & Obstetrics
Figure 31. Global Gynecology & Obstetrics Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Gastroenterology
Figure 33. Global Gastroenterology Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Oncology
Figure 35. Global Oncology Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Cardiology
Figure 37. Global Cardiology Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Global Intravenous (IV) Iron Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Intravenous (IV) Iron Drugs Sales Market Share by Application in 2022 & 2034
Figure 42. North America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application in 2022
Figure 43. North America Intravenous (IV) Iron Drugs Sales Market Share in Value by Application in 2022
Figure 44. Europe Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Europe Intravenous (IV) Iron Drugs Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Intravenous (IV) Iron Drugs Sales Market Share in Value by Application in 2022
Figure 48. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Intravenous (IV) Iron Drugs Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Intravenous (IV) Iron Drugs Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Intravenous (IV) Iron Drugs Manufacturing Cost Structure
Figure 53. Intravenous (IV) Iron Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries